Cyclophosphamide, Fludarabine and Antithymocyte Globulin Conditioning in Myelodysplastic Syndrome (MDS)

Clinical trial NCT01255319 · UNKNOWN

Trial details

NCT number: NCT01255319
Sponsor: Cooperative Study Group A for Hematology
Status: UNKNOWN
Study type: OBSERVATIONAL

Myelodysplastic Syndrome

Start date: 2010-11-01
Primary completion: 2012-11-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.